Results from an early safety study of Moderna Inc's coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at levels similar to those seen in younger adults, with side effects roughly on par with high-dose flu shots,...
Moderna Inc said on Friday it was on track to produce 20 million doses of its experimental coronavirus vaccine by the end of the year, while maintaining its goal of readying 500 million to 1 billion doses in 2021.
AstraZeneca said it paused clinical trials of an experimental Covid-19 vaccine after a participant in a U.K. study had an unexplained illness.
Top U.S. infectious diseases expert Anthony Fauci said on Thursday it is unlikely a COVID-19 vaccine will be ready by the end of October, but that it is not impossible.
Decision is ‘real blow’ to Covax project, expert says, with White House blaming stance on role of WHO and China
Moderna said its experimental coronavirus vaccine induced immune responses in people aged 56 years and older that were comparable to those seen in younger adults in a small study.
Nearly a fifth of 11,000 people enrolled so far in a 30,000-volunteer U.S. trial testing a COVID-19 vaccine from Pfizer and German partner BioNTech are Black or Latino, groups among the hardest hit by the coronavirus virus pandemic, a top Pfizer executive said.
The administration has bought initial vaccine batches from several pharmaceutical companies.
I wrote a blog post over the weekend that has generated tremendous pushback, including an op-ed in the New York Times as well as thousands of comments on Twitter. I was wrong.
(AP) — Who gets to be first in line for a COVID-19 vaccine? U. S. health authorities hope by late next month to have some draft guidance on how to ration initial doses, but it’s a vexing decision. “Not everybody’s going to like the answer,” Dr. Francis Collins, director of the National Institutes of Health, recently told one of the advisory groups the government asked to help decide. “There will be many people who feel that they should have been at the top of the list. ”
An experimental vaccine being developed by AstraZeneca and Oxford University against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of the year.
The race to develop a COVID-19 vaccine is heating up globally and right here in our area. In Seattle, we’ve got a lot of companies and volunteers doing their part to try and help. “It’s been 16 weeks since I had the first dose," said Jennifer Haller of Ballard. "I feel fantastic. " On March 16, Haller, a 43-year-old a tech startup operations manager, became the first person in the country to get injected with the experimental COVID-19 vaccine.
Food and Drug Administration (FDA) Commissioner Stephen Hahn said Sunday that he would not make a prediction about when a coronavirus vaccine would be available after President Trump claimed that a vaccine or therapeutic would be ready "long
More than 140 teams of researchers are racing to develop a safe and effective coronavirus vaccine
Percentage of stock U.S. households own determines the market’s 10-year return, writes Mark Hulbert.
Distrust of vaccines is main reason for 50% of those who wouldn't get one, a new ABC News/Washington Post poll found.
It's likely to tap into its military know-how to get the vaccines out faster.
U.S. pharmacy chains are preparing a big push for flu vaccinations when the season kicks off in October, hoping to curb tens of thousands of serious cases that could coincide with a second wave of coronavirus infections.
U.S. stock futures surged on Tuesday, with investors set to return from the long Memorial Day weekend. News that human trials have begun for a potential...
A quarter of Americans have little or no interest in taking a coronavirus vaccine, a Reuters/Ipsos poll published on Thursday found, with some voicing concern that the record pace at which vaccine candidates are being developed could compromise safety.
World's No.2 cigarette company British American Tobacco said on Friday it was ready to test its potential COVID-19 vaccine using proteins from tobacco leaves on humans, after it generated a positive immune response in pre-clinical trials.
Rick Bright will start his new job in a role inside the federal government's coronavirus response next week, his attorneys said Thursday.
Researchers report that they have identified a fully human monoclonal antibody that prevents the SARS-CoV-2 (COVID-19) virus from infecting cultured cells. The discovery is an initial step towards developing a fully human antibody to treat or prevent the respiratory disease COVID-19 caused by the novel coronavirus SARS-CoV-2.
Efforts to develop a jab should not become a competition between countries, PM insists - but US sits out virtual global summit
The British pharmaceutical giant has agreed to manufacture and distribute an experimental vaccine from the University of Oxford—one of the most advanced candidates—in a partnership aimed at accelerating the widespread availability of the shot if it proves effective.
Rochester, N. Y. - Local researchers are preparing to test a vaccine that could help prevent COVID-19. Rochester Clinical Research is seeking healthy volunteers between ages 19 to 85. For 25 years, RCR has conducted vaccine tests. The process to develop a vaccine for Ebola, a disease similar to the coronavirus, took more than five years. COVID-19 has crushed that timeline. "That's a long time," Adam Larrabee, RCR's president, said of the Ebola vaccine.
Dressed in a hazmat suit, two masks and a face shield, Du Mingjun knocked on the mahogany door of a flat in a suburban district of Wuhan on a recent morning.
Australia's national science agency said on Thursday it has commenced the first stage of testing potential vaccines for COVID-19, as it joins a global race to halt the coronavirus pandemic.
Bill Gates addresses concerns over coronavirus via AMA session on Reddit. He also cleared that COVID-19 had nothing to do with his retirement from Microsoft.
Covid-19 essential guide: can it be caught on public transport, how is it different from the flu, and how sick will I get?
Donald Trump asked medical experts if coronavirus could be treated with a flu vaccine that already exists at a meeting with pharmaceutical executives on Monday. The Trump administration called the meeting to discuss early work for developing a vaccine for the virus, which has killed more the 3,000 people and infected nearly 90,000 worldwide.